Universal CD19 CAR-γδT cell therapy

· The Second Affiliated Hospital of Fujian Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Universal CD19 CAR-γδT cell therapy, covering 2026-01-26 to 2026-01-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study of Universal CD19 CAR-γδT Cell Injection in the Treatment of Adult Relapsed/Refractory B-cell Lymphoma [Phase 1]

See pricing